Cabenuva is a newly approved injectable product that can be used to help treat HIV-1. Want to learn more about its pros and cons? Learn more now!
Author: David Kaylor
David M. Kaylor, PharmD has pharmacy practice experience primarily in the inpatient (hospital) setting. David’s primary interests are related to infectious diseases, anticoagulation, and heart failure. Currently, David is a PGY1 pharmacy resident at UofL Health – UofL Hospital in Louisville, KY. In his free time, David enjoys playing guitar, watching documentaries, and rooting for the Indianapolis Colts and Indiana Pacers. David is a proud graduate of the Doctor of Pharmacy (PharmD) program at Butler University in Indianapolis, IN. David is a licensed pharmacist in Kentucky, USA.
Navigating the Commonly Listed Opioid Allergy
Opioid allergies are a commonly documented allergy in many patients' medical records. What thoughts go through the mind of a pharmacist when treating a patient with pain that has a…
A Balancing Act: CDC Updates to Treatment Guidelines for Gonorrhea and Impact on Treatment of Chlamydia
The treatment of gonorrhea has had some recent updates published in December 2020 - read here for a simplified version of the new CDC guidance.